Loading…

Anupam Rasayan signed a 10-year letter of intent valued at $106 million (approx. ₹922 crore) with a Korean multinational for a high-performance niche chemical for defence and aerospace. Commercialisation is expected to start in FY2025-26.
“This is again a speciality chemical, mainly on the polymer side, which is going to go into applications that are more niche, particularly in the defence and aerospace segment.”cnbctv18.com
Summarized from public sources; check the original articles before acting on it.